Your browser doesn't support javascript.
loading
Experience of Nivolumab Prior to Autologous Stem Cell Transplant for Relapsed Refractory Hodgkin Lymphoma.
Patel, Jaikumar; Garg, Akanksha; Patel, Kinnari; Shah, Kamlesh; Shah, Sanket; Yadav, Rajan; Anand, Asha; Panchal, Harsha; Patel, Apurva; Parikh, Sonia; Shah, Sandip.
Affiliation
  • Patel J; Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, India.
  • Garg A; Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, India.
  • Patel K; Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, India.
  • Shah K; Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, India.
  • Shah S; Hemato-Oncology Clinic Vedanta, Ahmedabad, India.
  • Yadav R; Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, India.
  • Anand A; Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, India.
  • Panchal H; Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, India.
  • Patel A; Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, India.
  • Parikh S; Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, India.
  • Shah S; Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, India.
Indian J Hematol Blood Transfus ; 38(3): 585-590, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35747573

Full text: 1 Database: MEDLINE Type of study: Observational_studies Language: En Journal: Indian J Hematol Blood Transfus Year: 2022 Type: Article Affiliation country: India

Full text: 1 Database: MEDLINE Type of study: Observational_studies Language: En Journal: Indian J Hematol Blood Transfus Year: 2022 Type: Article Affiliation country: India